ANJ-028

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameANJ-028
Drug Alias NameANJ-028
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApolipoprotein E agonists
TargetsApolipoprotein E
Therapy Area/IndicationsHomozygous familial hypercholesterolemiaAcute Coronary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAnji Pharma (Shanghai) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnji Pharma (Shanghai) Ltd
Inactive CompaniesN/A
Active IndicationsHomozygous familial hypercholesterolemiaAcute Coronary Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A